Clinical Trial Update: Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial investigating chemotherapy plus erlotinib for unresectable esophageal or gastroesophageal cancer; study terminated with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: University of California, San Francisco | Conditions: Esophageal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-10-12